erythromycin has been researched along with Periphlebitis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lanbeck, P; Odenholt, I; Riesbeck, K | 1 |
| Kilic, B; Kruse, M; Stahlmann, R | 1 |
| Flick, B; Kilic, B; Kruse, M; Stahlmann, R | 1 |
| Finch, RG; Macfarlane, JT; Rose, DH; Ward, MJ | 1 |
| de Dios García-Díaz, J; Moreno-Vázquez, M; Paz Martínez Ortega, M; Santolaya Perrín, R | 1 |
| David, LM | 1 |
| Gaskins, J; Holt, RJ | 1 |
| Nankervis, GA | 1 |
1 trial(s) available for erythromycin and Periphlebitis
| Article | Year |
|---|---|
Erythromycin compared with a combination of ampicillin and amoxycillin as initial therapy for adults with pneumonia including Legionnaires' disease.
Topics: Adult; Aged; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Female; Humans; Legionnaires' Disease; Male; Middle Aged; Phlebitis; Pneumonia | 1983 |
7 other study(ies) available for erythromycin and Periphlebitis
| Article | Year |
|---|---|
Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cells: a possible factor in the pathogenesis of infusion phlebitis.
Topics: Anti-Bacterial Agents; Cell Line; Dicloxacillin; Endothelial Cells; Erythromycin; Flow Cytometry; Humans; Infusions, Intravenous; Intercellular Adhesion Molecule-1; Penicillins; Phlebitis; Thromboplastin; Tumor Necrosis Factor-alpha; Up-Regulation | 2004 |
The in vitro effects of quinupristin/dalfopristin, erythromycin and levofloxacin at low concentrations on the expression of different cell adhesion molecules on the surface of endothelial cells (Eahy926).
Topics: Anti-Bacterial Agents; Cell Adhesion Molecules; Cell Line; Dose-Response Relationship, Drug; Endothelial Cells; Erythromycin; Flow Cytometry; Humans; Levofloxacin; Ofloxacin; Phlebitis; Virginiamycin | 2006 |
Effect of quinupristin/dalfopristin on 3T3 and Eahy926 cells in vitro in comparison to other antimicrobial agents with the potential to induce infusion phlebitis.
Topics: Animals; Anti-Bacterial Agents; BALB 3T3 Cells; Cell Survival; Dose-Response Relationship, Drug; Endothelial Cells; Erythromycin; Fibroblasts; Humans; Infusions, Intravenous; Inhibitory Concentration 50; Levofloxacin; Mice; No-Observed-Adverse-Effect Level; Ofloxacin; Phlebitis; Reproducibility of Results; Toxicity Tests; Virginiamycin | 2007 |
[Phlebitis due to intravenous administration of macrolide antibiotics. A comparative study of erythromycin versus clarithromycin].
Topics: Anti-Bacterial Agents; Clarithromycin; Erythromycin; Female; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Phlebitis; Prospective Studies | 2001 |
Phlebitis with intravenous erythromycin.
Topics: Erythromycin; Humans; Injections, Intravenous; Phlebitis | 1987 |
Phlebitis with intravenous erythromycin.
Topics: Erythromycin; Humans; Injections, Intravenous; Phlebitis | 1986 |
Bacterial meningitis.
Topics: Adult; Aged; Ampicillin; Brain Abscess; Child; Chloramphenicol; Diagnosis, Differential; Erythromycin; Female; Humans; L-Lactate Dehydrogenase; Male; Meningitis; Meningitis, Haemophilus; Meningitis, Listeria; Meningitis, Meningococcal; Meningitis, Pneumococcal; Meningitis, Viral; Middle Aged; Penicillin G; Penicillin Resistance; Phlebitis; Prognosis; Sinus Thrombosis, Intracranial; Staphylococcus; Tetracycline; Tuberculosis, Meningeal; Urinary Tract Infections | 1974 |